Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum- sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study

Rafli van de laar, Petra L. M. Zusterzeel, Toon Van Gorp, Marrije R. Buist, Willemien J. van Driel, Katja N. Gaarenstroom, Henriette J. G. Arts, Johannes C. M. van Huisseling, Ralph H. M. Hermans, Johanna M. A. Pijnenborg, Eltjo M. J. Schutter, Harold M. P. Pelikan, Jos H. A. Vollebergh, Mirjam J. A. Engelen, Joanna IntHout, Roy F. P. M. Kruitwagen, Leon F. A. G. Massuger

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number22
JournalBMC Cancer
Volume14
DOIs
Publication statusPublished - 14 Jan 2014

Keywords

  • Secondary cytoreductive surgery
  • Recurrent
  • Platinum-sensitive
  • Ovarian cancer

Cite this

van de laar, R., Zusterzeel, P. L. M., Van Gorp, T., Buist, M. R., van Driel, W. J., Gaarenstroom, K. N., Arts, H. J. G., van Huisseling, J. C. M., Hermans, R. H. M., Pijnenborg, J. M. A., Schutter, E. M. J., Pelikan, H. M. P., Vollebergh, J. H. A., Engelen, M. J. A., IntHout, J., Kruitwagen, R. F. P. M., & Massuger, L. F. A. G. (2014). Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum- sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study. BMC Cancer, 14, [22]. https://doi.org/10.1186/1471-2407-14-22